ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207;

Stock News for Mylan Inc. (MYL)
01/21/201614:57:00Mylan to Report Fourth Quarter and Full Year 2015 Financial Results...
01/19/201610:26:00Mylan Launches Generic Felbatol® Tablets
01/11/201617:16:38Current Report Filing (8-k)
01/11/201617:11:00Mylan Confirms FDA Submission of ANDA for Generic Advair Diskus®
01/08/201617:19:42Current Report Filing (8-k)
01/08/201609:50:00Momenta, Mylan to Jointly Develop Six Biosimilars
01/08/201609:00:00Mylan CFO John Sheehan to Retire as of April 1, 2016
01/08/201608:00:00Mylan Announces Worldwide Collaboration with Momenta to Jointly...
01/08/201608:00:00Momenta Pharmaceuticals Announces Worldwide Collaboration With...
01/08/201608:00:00Momenta Pharmaceuticals Announces Worldwide Collaboration With...
01/07/201608:00:00Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under...
01/05/201610:34:00Mylan Launches Generic Ortho Tri-Cyclen Lo® Tablets
01/02/201603:02:00Bests And Bloopers From M&A's Epic Year
12/29/201507:00:00Mylan Launches Generic Zyvox® Tablets
12/17/201507:15:00Mylan to Present at the Goldman Sachs Healthcare CEOs Unscripted:...
12/17/201507:00:00Mylan to Present at the J.P. Morgan 34th Annual Healthcare Conference
12/15/201517:18:56Current Report Filing (8-k)
12/08/201507:04:07Proxy Statement (definitive) (def 14a)
12/04/201516:36:00Mylan Announces Pricing of Senior Notes
12/04/201509:45:00U.S. Hot Stocks: Hot Stocks to Watch

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations